4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0002046433-26-000005
CMO and Head of R&D acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
McKee Charlotte · CMO and Head of R&D
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Grant or award : show line 1 in the form | +50,000 | 78,415 | D |
| 2026-09-17 | Grant or award : show line 2 in the form | +50,000 | 128,415 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) | +155,700 | 155,700 | D |
| 2026-09-17 | Returned to the company : show line 4 in the form Non-Qualified Stock Option (right to buy) | −155,700 | 0 | D |
Loading xslF345X06/edgardoc.xml…